Protect sensitive research, intellectual property, and operational systems with identity security tailored for hybrid and on-prem pharmaceutical environments.
Silverfort helps pharmaceutical companies with advanced identity security by extending multi-factor authentication (MFA) and strong access controls to critical systems, including R&D platforms, supply chain management tools, and legacy infrastructure. Seamlessly operating across hybrid and on-prem environments, Silverfort protects service accounts, mitigates risks like credential theft and lateral movement, and prevents unauthorized access. By securing sensitive intellectual property, maintaining regulatory compliance, and ensuring operational continuity, Silverfort helps pharmaceutical companies safeguard their innovations and resilience against evolving cyber threats targeting this highly regulated sector.
Replace point solutions with a single platform for all human and non-human identities, on-prem and in the cloud.
Enable security controls like MFA and JIT where no other solution can, from legacy systems to command-line tools.
No more endless implementations and user interruptions. Deploy seamlessly without modifying your existing systems.
The Silverfort Identity Security Platform
Configure MFA policies to trigger protection for detected risks, disabling adversaries from using compromised credentials for malicious access.
Set up a demo to see the Silverfort Identity Security Platform in action.